Oncology Clinical Trials in Tacoma, WA
As of September 2026, 51 paid clinical trials are recruiting for Oncology in Tacoma, Washington. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
51 clinical trials for Oncology
·Clear filters·A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
SLV-154 Treatment of Advanced Cancers
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
A Study of YL201 in Patients With Advanced Solid Tumors
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Project: Every Child for Younger Patients With Cancer
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Top Research Study Locations in Tacoma
Researchers run research studies in Tacoma, WA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mary Bridge Children's Hospital and Health Center | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Ganglioneuroblastoma, Nodular | 20 |
| Madigan Army Medical Center | Malignant Solid Neoplasm, Acute Myeloid Leukemia, ACDF Surgery | 18 |
| Northwest Medical Specialties | Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 18 |
| Northwest Medical Specialties, PLLC | Advanced Cancer, Metastatic Cancer, Advanced Solid Tumor | 13 |
| Washington Gastroenterology - Tacoma | Obesity or Overweight, Crohn's Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease | 10 |
| Northwest Medical Specialties Tacoma | Chronic Lymphocytic Leukemia, Multiple Myeloma, Non Small Cell Lung Carcinoma | 5 |
| GI Alliance Tacoma | Colitis, Ulcerative, Crohn Disease | 4 |
| MultiCare Institute for Research & Innovation | Crohn's Disease, Hypogonadism, Male, Metastatic Non-small Cell Lung Cancer | 4 |
| MultiCare Health System | Breast Neoplasms, Colitis, Ulcerative, Neoplasm Metastasis | 4 |
| Universal Research Group | Alzheimer Disease, Atherosclerotic Cardiovascular Disease (ASCVD), Dementia | 3 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 2 |
| Cortex Neurovascular / TRA Union | Migraine Disorders, Chronic Migraine, Chronic Migraine Headache | 2 |
| Mary Bridge Children's Hospital & Health Center | Cerebroside Lipidosis Syndrome, Gaucher Disease, Glucocerebrosidase Deficiency Disease | 2 |
| Northwest Medical Specialties PLLC | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Breast Cancer | 2 |
| Northwest Medical Specialties, PLLC - Tacoma | MF, Metastatic Castration-Resistant Prostate Cancer, Myelofibrosis | 2 |
| Washington Gastroenterology- GIA | Crohn's Disease, Ulcerative Colitis | 2 |
| MultiCare Institute for Research and Innovation | Percutaneous Coronary Intervention, Peripheral Endovascular Intervention, Migraine | 2 |
| MultiCare Mary Bridge Children's Health Center | Type 1 Diabetes Mellitus, Fabry Disease | 2 |
| Mary Bridge Children's Health | Sickle Cell Disease | 1 |
| 019 | Advanced Solid Tumor | 1 |
| Anthos Investigative | Atrial Fibrillation (AF) | 1 |
| CHI Franciscan Research Center | Heart Failure, Obesity | 1 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 1 |
| CommonSpirit Health Research Institute | Atrial Fibrillation, Stroke, Ischemic, Systemic Embolism | 1 |
Active & Upcoming Studies in Tacoma (2026)
Recruiting trials in Tacoma grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (66 active studies)
- An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC · Phase 3 · AstraZeneca
- Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS) · Phase 4 · Regeneron Pharmaceuticals
Diabetes & metabolic (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes · Phase 2 · SAb Biotherapeutics, Inc.
Neurology & pain (10 active studies)
- EMBRACE-OBS: Single-Site Observational Registry of Patient-Reported Outcomes Following MMA Embolization for Migraine · Cortex Neurovascular
- A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). · Phase 3 · Eli Lilly and Company
Cardiovascular (10 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention · Phase 4 · Duke University
Mental health & behavior (1 active study)
- Lay-Delivered Behavioral Activation in Senior Centers · University of Washington
Common conditions studied in Tacoma
- Crohn's Disease (9 active studies)
- Ulcerative Colitis (8 active studies)
- Colitis, Ulcerative (7 active studies)
- Breast Cancer (5 active studies)
- Breast Neoplasms (5 active studies)
- Multiple Myeloma (5 active studies)
Leading research sponsors in Tacoma
- Children's Oncology Group
- AstraZeneca
- Eli Lilly and Company
- National Cancer Institute (NCI)
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Tacoma?
There are approximately 152 recruiting clinical trials in Tacoma, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tacoma pay participants?
Most recruiting trials in Tacoma compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tacoma?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tacoma?
The most common conditions under active study in Tacoma include Crohn's Disease (9), Ulcerative Colitis (8), Colitis, Ulcerative (7), Breast Cancer (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tacoma?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tacoma on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tacoma?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tacoma?
Recruiting research sites in Tacoma include Mary Bridge Children's Hospital and Health Center, Madigan Army Medical Center, Northwest Medical Specialties, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tacoma right now?
The largest active categories in Tacoma are Cancer & tumors (66), Diabetes & metabolic (10), Neurology & pain (10). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.